Featured Story

Curetis nabs $18M to support European Dx rollout, U.S. trial, possible IPO

With its sights set on growth, German diagnostics outfit Curetis AG has closed a $18.1 million Series B financing round with new investor Qiagen chipping in.

Job cuts cost Hologic $52M in 2014

Hologic's effort to cut costs by slimming down its staff came at a price this year. The Bedford, MA-based diagnostics giant was hit with $51.7 million in restructuring charges in 2014, according to a regulatory filing.

LabCorp and CareDx call it quits on partnership to develop lupus test

LabCorp and CareDx have officially pulled the plug on a previously announced agreement to develop a lupus flare predictor test after completing the first phase of their collaboration.

Indian startup develops low-cost, portable Dx for developing countries

Amid growing demand for portable, low-cost diagnostics, Indian startup Swasthya Slate is developing a device that could help reduce costs and improve outcomes for patients in developing countries.

Illumina and bioMérieux to develop innovative sequencing system for infectious diseases

As the diagnostics industry explores innovative ways to monitor and contain bacterial infections, Illumina is joining forces with French diagnostic outfit bioMérieux to develop a next-generation sequencing system that can identify infectious bacteria in service labs and hospitals.